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Psychotic and mood disorders are brain dysfunctions that are caused by gene 
environment interactions.  Although these disorders are disadvantageous and involve 
behavioral phenotypes that decrease the reproductive success of afflicted individuals in 
the modern human society, the prevalence of these disorders have remained constant in 
the population.  Here, we propose several biological mechanisms by which the genes 
associated with psychotic and mood disorders could be selected for in specific 
environmental conditions that provide evolutionary bases for explanations of when, why, 
and where these disorders emerged and have been maintained in humans.  We discuss 
the evolutionary origins of psychotic and mood disorders with specific focuses on the 
roles of dopamine and serotonin in the conditions of social competitiveness/hierarchy 






Psychotic and mood disorders such as schizophrenia (SCZ) and major depressive 
disorder (MDD) are devastating mental problems with symptoms that include cognitive 
dysfunction and affective disturbance.  Epidemiological studies have reported that the 
fecundity rates of subjects with psychotic and mood disorders are significantly lower 
than those of normal subjects (Power et al., 2013), which suggests that the symptoms of 
these disorders are disadvantageous behavioral phenotypes, at least in modern human 
society.  Nevertheless, psychotic and mood disorders have been present at constant 
incidences in humans since an ancient era (Berrios, 1988; Kyziridis, 2005).  A major 
question is why psychotic and mood disorders emerged and have been maintained at a 
constant prevalence in humans despite natural selection, which predicts the elimination 
of phenotypes that do not match the environment.   
 By drawing evidence together from a range of published research, we present 
mechanisms of gene-environment interactions that may have played roles in the 
selection and maintenance of alleles that increase the risks of psychotic and mood 
disorders in evolution.  We discuss this issue with a specific focus on the roles of 
dopamine (DA) and serotonin (5-HT) transmission in (1) social 
competitiveness/hierarchy, (2) maternal care, (3) social network homophily, and (4) 
symbiosis. 
 
2. Positive Selection of Genes Associated with Psychotic and Mood 
Disorders 
Genetic factors play roles in psychotic and mood disorders.  The heritability rates of 
psychiatric disorders, including psychotic and mood disorders, are estimated to be 
approximately 0.4-0.8 depending on the type of disorders (Eaton et al., 2008; Sullivan et 
al., 2012).  Several genetic mechanisms may answer the questions of how and why 
disadvantageous alleles that increase the risks of psychotic and mood disorders have 
been selected for and maintained despite natural selection in evolution.  These 
potential mechanisms are not mutually exclusive and are intermingled in terms of the 
causes of disorders. 
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 One possible explanation is that de novo mutations of genes occur rarely but 
yield large effects (Gratten et al., 2014; Malhotra and Sebat, 2012; Sullivan et al., 2012).  
Because de novo mutations may occur at a constant rate, such mutation could explain 
the constant prevalence of psychotic and mood disorders even given the decreased 
fecundity of patients (Malhotra and Sebat, 2012).  Sporadic cases of SCZ and autism 
spectrum disorder (ASD) with no family histories have been reported (Cuccaro et al., 
2003; Lewis et al., 1987; Roy and Crowe, 1994), and de novo mutations may play 
significant roles in such cases.  However, because the frequency of de novo mutations 
is extremely low, it is estimated that only a fraction of cases at most can be explained by 
de novo mutations (Gratten et al., 2014; Malhotra and Sebat, 2012; Sullivan et al., 2012).  
Thus, other mechanisms should also be involved.  
 The neutral selection of genes (Kimura, 1968; Kimura and Ohta, 1971) is 
another possible explanation.  The effect of each allele associated with psychotic and 
mood disorders is too small to yield either an advantageous or disadvantageous 
influence, and the allele consequently escapes the selection process.  However, when 
these alleles with small effects are combined, symptomatic conditions may emerge.  
Common genetic variants with small effect sizes that increase the risks (odds ratios) of 
psychiatric disorders, including psychotic and mood disorders, by approximately 
1.05-1.2 at most have been identified (Gratten et al., 2014).  Such common alleles are 
estimated to account for 30-50% of cases due to the accumulated contributions of 
multiple alleles (Gratten et al., 2014).  Ripke and colleagues estimated that 50% of 
SCZ cases could be explained by 8,332 single nucleotide polymorphisms (SNPs) (Ripke 
et al., 2013).   
 An alternative explanation depends on the notion that an allele or a set of 
alleles associated with psychotic and mood disorders yield small but significant effects 
that are disadvantageous and thereby subjected to natural selection; however, such 
disadvantageous phenotypes are maintained by balancing selection because they can 
also function advantageously in specific environmental conditions.   
 Explorations of the evolutionary origins of human diseases have been 
attempted in the field of evolutionary medicine (Gluckman et al., 2011).  Evolutionary 
medicine is distinct from conventional biomedical research in that it emphasizes the 
understanding of "why" rather than "how" diseases are caused.  Trade-offs in 
biological function during evolution are thought to be involved in many human diseases.  
For example, erect bipedalism enabled free hand use in hominids, but the trade-offs 
include diseases such as thrombophlebitis and herniated lumber vertebral disks 
(Haeusler et al., 2013).  The loss of urase oxidase activity in several species, including 
humans and non-human primates, resulted in prolonged longevity due to the 
anti-oxidant effects of uric acid; however, the accumulation of uric acid also causes 
gouty arthritis (Johnson et al., 2009).   
 Environments are critical determinants of the selection of genetic variants 
based on the behavioral phenotypes that result from mutations.  The sickle cell trait is 
caused by nonsynonymous mutations of the β-globin gene that result in amino acid 
sequence changes that alter red blood cell structure and function (Rees et al., 2010).  
Sickle cell disease occurs in various types that are determined by the parts of the 
β-globin in which the mutations occur (Rees et al., 2010).  The most common mutation 
is caused by an A --> T SNP that results in the replacement of glutamic acid with valine 
(Rees et al., 2010).  Sickle cell mutation homozygosity is often lethal, and 
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heterozygotes suffer from disadvantageous phenotypes that include anemia.  
Nevertheless, a high prevalence of this genotype has been maintained in malaria 
epidemic regions in Africa, because this genotype confers resistance to malaria infection 
(Beutler et al., 1955).  Thus, specific environmental factors can preserve genotypes 
associated with diseases that are disadvantageous in normal conditions.   
 Whether psychotic and mood disorders involve balancing selection forces 
similar to those that affect sickle cells remains unknown.  Nevertheless, because 
environmental risk factors such as stress play significant roles in most if not all 
psychotic and mood disorders (Burt, 2009; Hammen, 2005; Lewis and Levitt, 2002; 
Rabkin, 1980; Schmitt et al., 2014), the mechanisms that sufficiently explain the causes 
of psychotic and mood disorders should be considered within the framework of 
gene-environment interactions with or without epigenetic mechanism and not in the 
framework of genetic variants alone.     
 
3. Are Psychotic and Mood Disorders Uniquely Nested in Human 
Evolution? 
A study by Crespi and colleagues (Crespi et al., 2007) demonstrated that traces of 
positive selection, selective sweep (i.e., reductions in genetic variations in the vicinity 
of variants under positive selection due to hitch-hiking effects among population 
(Nielsen et al., 2007)) and the dN/dS ratio (i.e., the ratio of non-synonymous to 
synonymous variants (Kimura, 1977)) are found approximately twice more frequently 
among SCZ candidate genes than other control genes (i.e., those associated with 
neuronal activity).  Additionally, a study by Ogawa and Vallender revealed that the 
dN/dS ratios of the genes that are homologous to SCZ and ASD candidate genes are 
significantly higher in catarrhini (old world monkeys, anthropoids, and humans) and 
cetacea (dolphins and whales) than other species of animals, which suggests that the 
alleles associated with SCZ and ASD have been subjected to positive selection and have 
played important roles in the evolutions of the brains of species such as catarrhini and 
cetacea with brain sizes that are larger than those of other species (Ogawa and Vallender, 
2014).  If such alleles are involved in the expansion of the size of the brain, this 
finding would explain how catarrhine primates and cetaceans acquired superior social 
intelligence. 
 Whether psychotic and mood disorders are unique human conditions that are 
not present in other animals essentially remains unknown because no systematic 
research has been conducted to answer this question.  However, behavioral 
manifestations that are highly similar to MDD-like states have often been observed in 
captive macaques (Camus et al., 2014; Xu et al., 2015), which suggests that some 
psychotic and mood conditions may not be exceptional in humans but rather might 
extend to at least some non-human animals such as catarrhine primates.  More 
importantly, psychotic and mood disorders are often characterized not only by deficits 
of higher brain function but also by more rudimentary behavioral traits that are observed 
across different animal species, such as impulsivity, aggression, stereotypy, and anxiety.  
These behavioral traits consist of core symptoms and are quite often observed across 
different categories of psychiatric disorders, including psychotic and mood disorders 
(Ouzier, 2013).  Given that these behavioral traits are found in animal species other 
than those of catarrhini and cetacea, the evolutionary origins of some aspects of 
psychiatric symptoms, such as impulsivity and aggression, may not necessarily be 
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limited to Homo species. 
 
4. Social Competitiveness/Hierarchy as an Evolutionary Origin of 
Psychotic and Mood Disorders 
Here, we discuss trade-offs similar to those associated with sickle cells that may have 
been established between DA- and 5-HT-dependent cognitive/affective function and 
some behavioral traits that are associated with psychotic and mood disorders.  
Specifically, impulsivity and aggression may work advantageously in specific 
conditions, such as those related to social competitiveness and consequent social 
hierarchical organization.  Thus, the alleles of the DA and 5-HT genes that are 
associated with increased risks of psychotic and mood disorders may have been 
maintained among animals and humans living in hierarchical societies through 
balancing selection. 
 Humans and most other animals live in social groups that yield various benefits 
such as the facilitation of reproduction and protection from predators by cooperation 
among subjects in the groups.  In many cases of such social groups, social hierarchy 
exists as an emergent property that results from competition among individuals, 
although recent evidence also suggests that social hierarchy could be a mechanism with 
more self-organizing adaptive features that are determined by differences in individual 
attributes and social interaction dynamics (Chase et al., 2002; Corominas-Murtra et al., 
2013; David-Barrett and Dunbar, 2012; Franz et al., 2015; Hobson and DeDeo, 2015).  
The tolerance of social hierarchy varies between species; some species organize very 
strict social hierarchies, whereas other species exhibit more relaxed social hierarchies 
(Thierry, 2007).  Human social systems are substantially different from those of many 
primates in pair-bonding, paternal care, cooperative breeding and an unusually high 
level of social cooperation.  Indeed, because the invention of agriculture and 
pastoralism, humans have adopted a sedentary lifestyle and have gradually progressed 
into more stratified, non-egalitarian social systems.  Nevertheless, during human 
evolution, humans have definitely been exposed to very severe competition in many 
different aspects both within group and between groups.  In particular, the social 
hierarchy of humans, especially that of young children, has been demonstrated to be 
substantially similar to that of non-human primates (Hawley, 1999; Koski et al., 2015), 
which suggests that mutual biological mechanisms may play roles in the social 
hierarchies of both human children and non-human primates.  Although reproductive 
success is not solely determined by social dominance but rather involves various factors, 
meta-analyses and reviews of the literatures have clearly demonstrated that social 
dominance is one of the most important factors in terms of the reproductive success in 
non-human primates (Ellis, 1995; Gowlishaw and Dumbar, 1991; Majolo et al., 2012), 
and this is true even in species that have highly relaxed hierarchies such as Assamese 
macaques (Schulke et al., 2010).  Although social hierarchy is strongly associated with 
reproductive success in males, this is less clear in females (Ellis, 1995), such that the 
following arguments about the roles of social competitiveness and consequent social 
hierarchy in the selection of psychotic and mood disorder-associated genotypes may be 
mostly applicable to males.   
 Investigations seeking to understand the biological mechanisms that underpin 
social competitiveness and the construction of social hierarchies have been conducted in 
various species of animals and humans.  Among the many factors that are involved in 
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social hierarchy (Koski et al., 2015), behavioral traits such as aggression and 
impulsivity have been demonstrated to play important roles in determining social class 
and hence can play crucial roles in attaining a high level of reproductive success.  Thus, 
animals such as non-human primates and rodents (Ferrari et al., 1998; Machida et al., 
1981; Morgan et al., 2000) and impulsivity (Fairbanks et al., 2004) have been shown to 
be placed in higher the social class in their groups.  Even in humans, aggression and 
impulsivity should have played crucial roles in severe contexts such as tribal warfare, 
which must have been quite frequent during human evolution, although it does 
obviously depend on the situation.  This notion is particularly interesting because 
impulsivity and aggression work advantageously in gaining higher social class, but 
these behavioral traits are treated as disadvantages in the modern human society and are 
associated with various psychiatric disorders including psychotic and mood disorders 
(Courtet et al., 2011; Mann et al., 2009; Robbins et al., 2012).   
 
4.1. DA 
Mesocortical and mesolimbic DA innervations from the ventral tegmental area into the 
prefrontal cortex (PFC) and nucleus accumbens (NAcc), respectively, play crucial roles 
in brain function such as reinforcement learning, goal-directed behavior, and cognitive 
functions, such as working memory, sustained attention, and behavioral flexibility 
(Dunnett and Robbins, 1992; Grace et al.; Seamans and Yang, 2004).  DA deficits have 
been implicated in SCZ (Howes and Kapur, 2009).  Antipsychotic drugs for the 
treatment of SCZ have DA D2 receptor antagonistic properties (Seeman, 2011), 
although no consistent results related to D2 receptor expression changes have been 
reported in postmortem or functional imaging studies of patients (Davis et al., 1991; 
Howes and Kapur, 2009; Kambeitz et al., 2014; Sedvall, 1990; Soares and Innis, 1999).  
Positron emission tomography (PET) imaging studies in SCZ patients have also 
reported alterations of PFC D1 receptor availability, although the results are inconsistent 
and include a mixture of findings demonstrating increases (Abi-Dargham et al., 2012; 
Poels et al., 2013), decreases (Kosaka et al., 2010; Okubo et al., 1997), or no change 
(Kambeitz et al., 2014; Karlsson et al., 2002) in D1 receptor availability. 
 Accumulating evidence suggests that DA transmission is involved in the 
organization of social hierarchy.  The dopamine transporter (DAT) plays a primay role 
in the regulation of nigrostriatal and mesolimbic DA release (Kuhar et al., 1990).  
Following the development of DAT knockout mice, the functional significance of DAT 
in the cognitive and affective domains has been extensively investigated in rodents 
(Gainetdinov, 2008).  Social groups consisting of DAT knockout mice have been 
demonstrated to organize more unstable hierarchies relative to groups of normal mice 
(Rodriguiz et al., 2004).  The cerebrospinal fluid (CSF) concentration of the DA 
metabolites homovanilic acid has also been found to be higher in subordinates than 
dominants (Nader et al., 2012).  A study using a socially housed non-human primate 
model of parkinsonian with MPTP-treatments demonstrated a shift of social rank in the 
middle class monkey in the group following a low-dose MPTP administration, and this 
monkey returned to its original rank following a high-dose MPTP administration 
(Durand et al., 2015).   
 The roles of D1 receptor signaling in cognitive function and PFC information 
processing have been extensively investigated and well characterized (Seamans and 
Yang, 2004).  For example, the local infusion of a D1 antagonist into the PFC of 
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non-human primates (Goldman-Rakic et al., 2000) and rodents (Seamans et al., 1998) 
has been demonstrated to impair working memory and disrupt the sustained firing of 
PFC neurons during delay periods in a working memory task.  The administration of a 
D1 antagonist also impairs other domains of cognitive function, such as behavioral 
flexibility (Ragozzino, 2002) and associative learning (Puig et al., 2014).  In humans, 
two SNPs, i.e., rs4532 (A-48G) and rs5326 (G-94A), in the 5'UTR of the DRD1 gene 
have been identified.  The associations of these SNPs with increased risks of SCZ are 
controversial; a meta-analysis of the SZGene database reported no association (Allen et 
al., 2008), but another meta-analysis of the literatures reported a weak association with 
the DRD1 gene variant rs5326 (Pan et al., 2014).  
 Although low D1 receptor function impairs cognitive function, it could 
facilitate fitness benefits of individuals living in a hierarchical social system.  A human 
PET imaging study has demonstrated that limbic and striatal D1 receptor availabilities 
are positively correlated with social affiliation and negatively correlated with social 
dominance and aggression such that subjects with higher D1 receptor availability are 
less dominant and aggressive and more affiliative with others (Plaven-Sigray et al., 
2014).  Among rodents, one mouse strain, i.e., BALB/c mice, exhibit more aggressive 
behavior than another strain, i.e., A/J mice.  This difference is correlated with lower 
PFC and striatal D1 receptor expression in the BALB/c mice than the A/J mice 
(Couppis et al., 2008).  In addition, the administration of a D1 antagonist to rats has 
been found to induce frequent impulsive choices in a delayed-discounting task (van 
Gaalen et al., 2006).  Collectively, it is possible that a trade-off might have been 
established between cognitive function and behavioral traits, such as impulsivity and 
aggression, which are important determinants of the social class of individuals in the 
hierarchy such that genetic variants that determine D1 receptor function may have been 
subjected to balancing selection through evolution. 
 DA D2 receptor signaling also plays important roles in cognitive function. In 
human studies, D2 agonist treatments have been found to enhance working memory 
(Kimberg et al., 1997; Luciana et al., 1992; Muller et al., 1998) and behavioral 
flexibility (van Holstein et al., 2011), although these effects depend on working memory 
capacity (Kimberg et al., 1997) and the genetic backgrounds (van Holstein et al., 2011) 
of the subjects.  A number of DRD2 SNPs have been identified and associated with 
increased risks of SCZ and mood disorders (Zou et al., 2012).  Meta-analyses and 
large-scale genome-wide association studies (GWAS) have demonstrated significant 
associations of several DRD2 SNPs, i.e., rs2514218 (Schizophrenia Working Group of 
the Psychiatric Genomics, 2014), rs1801028 (Ser311Cys) (Glatt and Jonsson, 2006; Liu 
et al., 2012; Yao et al., 2015), rs6277 (C957T) (Betcheva et al., 2009; Fan et al., 2010a; 
Monakhov et al., 2008), and rs1799732 (-141 Ins/Del) (Cordeiro et al., 2009), with 
increased risks of SCZ.  The functional significance of another DRD2 SNP, i.e., 
rs1800497 (TaqIA), has been extensively investigated (Grandy et al., 1989; Noble, 
2003).  A1-allele carriers exhibit lower striatal D2 receptor availability than A2-allele 
carriers (Pohjalainen et al., 1998; Thompson et al., 1997), which is linked to social 
problems such as extraverted personalities (Smillie et al., 2010).  Although a recent 
meta-analysis did not support the association of this SNP with SCZ (Yao et al., 2015), 
another meta-analysis concluded that there is an association with mood disorders (Zou 
et al., 2012).  Although the A1 allele would work disadvantageously in social function, 
the percentage of A1-allele carriers differs among ethnic groups.  Higher prevalence 
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(~40%) is present in Asians and African-American than in Europeans (~20%), and the 
prevalence could reach up to 80% in American-Indians (Goldman et al., 1993; Roman et 
al., 2013), which suggests that the A1-allele has been under evolutionary pressures in 
social environments that could vary among different ethnic groups.  However, the 
aspects of the social environments that play roles in the selection of this genotype have 
remained unclear.  The high prevalence of the A1 allele in American-Indians may also 
involve a bottleneck effect (i.e., significant reduction of the population size in the past) 
due to European colonization (O'Fallon and Fehren-Schmitz, 2011). 
 D2 receptor signaling is also involved in social hierarchy.  PET imaging in 
cynomolgus monkeys has revealed that there is no significant difference in D2 receptor 
availability in the striatum when monkeys are individually housed.  However, striatal 
D2 receptor availability becomes significantly higher in dominants than in subordinates 
when they are housed in a social group (Morgan et al., 2002).  In contrast, striatal D2 
receptor availability is positively correlated with social dominance (Cervenka et al., 
2010) and social status (Martinez et al., 2010), and negatively correlated with social 
affiliation (Cervenka et al., 2010), such that subjects with higher D2 availability are 
more dominant over others and experience higher socioeconomic status.  Collectively, 
D2 receptor function plays roles in social hierarchy, but it yields the opposite effects 
compared to those of D1 receptor function.  Thus, individuals with low D1 and high 
D2 receptor signaling are more likely to be of higher social class (dominants), whereas 
subjects with high D1 and low D2 receptor signaling are more likely to be of lower 
social class (subordinates).  Higher D2 receptor function is better for both cognitive 
function and social hierarchy, such that no apparent trade-off between social hierarchy 
and cognitive function in terms of D2 receptor function have been observed.  
Nevertheless, there are several individual fitness benefits of lower D2 receptor signaling 
for lower social class subjects in a hierarchy.  We provide two such examples in 
relation to (1) novelty seeking and (2) creativity. 
 First, D2 receptor function is associated with novelty seeking.  Studies in 
humans and rodents have demonstrated that subjects with lower D2 receptor expression 
or availability in brain regions such as the insula (Suhara et al., 2001), midbrain DA 
nuclei (Zald et al., 2008), and striatum (Tournier et al., 2013) exhibit greater the novelty 
seeking.  The A1 allele of the DRD2 TaqIA polymorphism has also been associated 
with greater novelty seeking in drug-addicted people (Han et al., 2008; Lin et al., 2007; 
Teh et al., 2012) and normal subjects (Noble et al., 1998) (but also see (de Brettes et al., 
1998) that reported no association) than non-allele carriers.  Novelty seeking works 
advantageously to individuals living in a hierarchical social group, especially when the 
group becomes over-populated.  Because the priority for accessing resources (e.g., 
foods) is given to subjects in the dominant class, the subordinates are unable to secure 
resources when the number of subjects in the group exceeds the capacity that the 
resources allow.  The behavioral tendency toward high novelty seeking would lead to 
exploration for resources outside of the group in such conditions.   
 Second, D2 receptor function is also associated with creativity.  In normal 
human subjects, lower D2 receptor availability in the thalamus is associated with higher 
creativity (de Manzano et al., 2010).  A genetic study has also reported that the DRD2 
TaqIA polymorphism A1 allele is associated with creativity (Reuter et al., 2006; Zhang 
et al., 2014).  Consistent with these findings, a number of studies in different species of 
animals, such as hyenas (Benson-Amram and Holekamp, 2012) and pigeons (Bouchard 
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et al., 2007), have demonstrated that creativity as measured by a variety of behavioral 
patterns exhibited during problem solving (e.g., taking chow out of an enclosed cage) is 
richer in animals that exhibit greater novelty seeking.  Indeed, creativity could aid the 
overcoming of intra-group conflictions and could enhance reproductive success of 
groups of low social class subjects. 
 Although highly speculative, the roles of D2 receptor function in social 
hierarchy along with behavioral traits, such as creativity and novelty seeking, may be 
able to explain evolutionary origins of SCZ.  First, novelty seeking for finding 
resources outside of the group by low social class subjects may eventually split the 
group.  This notion may be consistent with the group splitting hypothesis of SCZ 
proposed by Stevens and Price (Stevens and Price, 2000), which argues that SCZ traits 
are often observed in charismatic leaders who can lead and split a group when the group 
becomes too large.  Second, lower D2 receptor availability in the thalami of SCZ 
patients than normal subjects has been demonstrated (Yasuno et al., 2004).  The greater 
creativity of SCZ patients has also been demonstrated using Lovibond sorting test in 
which participants sort objects while the participants themselves create categories and 
creativity is assessed according to the number of invented sorting categories.  In this 
test, SCZ patients generate more categories than normal subjects.  In contrast, SCZ 
patients perform poorly in similar sorting tests in which the sorting is based on 
pre-designed rules, such as the Wisconsin card sorting test (Dykes and McGhie, 1976).  
Linkds between creativity and SCZ have also emerged from epidemiological and 
genetic studies.  A prospective epidemiological study of 1.2 million Swedish people 
over 40 years demonstrated that relatives, such as parents and siblings, of SCZ patients 
are more likely to hold creative jobs, although the patients themselves do not have such 
jobs (Kyaga et al., 2013).  A recent GWAS also demonstrated that SCZ susceptibility 
genes are also associated with creativity (Power et al., 2015).  Investigations of the 
associations between DA function, social hierarchy, novelty seeking, and creativity 
would provide a novel insights into the biological mechanisms of SCZ. 
 
4.2. 5-HT 
The transmission of 5-HT in the corticolimbic system plays important roles in affective 
function (Dayan and Huys, 2009; Hariri et al., 2006).  MDD is a mood disorder with 
affective dysfunction and its pathophysiology is thought to involve decreased 5-HT 
transmission in several brain regions including the hippocampus and PFC because 
selective serotonin reuptake inhibitors (SSRIs) exhibit therapeutic efficacy in MDD 
(Clark et al., 2009; Elliott et al., 2011; Kupfer et al., 2012), and serotonin transporter 
availability is higher in the thalami of MDD than normal subjects (Ichimiya et al., 2002).  
However, there are also controversial studies that have reported lower serotonin 
transporter availability in the PFC of MDD patients than in healthy subjects (Mann et al., 
2000; Meyer et al., 2004), which suggests that alterations in 5-HT transmission 
associated with MDD are complex and region-specific. 
 A 44-bp deletion/insertion variable number tandem repeat (VNTR) that 
generates 14 (s-allele) or 16 (l-allele) repeat variants in the promoter region of the 
serotonin transporter gene (SLC6A4) has been identified and is referred to as the 
serotonin transporter-linked polymorphic region (5HTTLPR) (Lesch et al., 1994). The 
s-allele has been associated with lower transcriptional serotonin transporter activity and 
therefore lower 5-HT reuptake than the l-allele (Heils et al., 1996).  Meta-analyses 
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have demonstrated a weak but significant association of the s-allele with an increased 
risk of mood disorders including MDD (Clarke et al., 2010; Lasky-Su et al., 2005; 
Lotrich and Pollock, 2004).  The tryptophan hydroxylase is a rate-limiting enzyme in 
5-HT synthesis (Mandell and Knapp, 1982).  The tryptophan hydroxylase gene is 
located at two loci, one in chromosome 11p15.3-14 and the other in 12q21.1, which are 
denoted as TPH1 and TPH2, respectively (Bennett et al., 2000).  Several SNPs have 
been identified in both TPH1 and TPH2, among which rs1800532 (A218C) (Gatt et al., 
2015; Gizatullin et al., 2006) and rs4570625 (G703T) (Gao et al., 2012) have been 
associated with mood disorders. 
 Human and non-human primate studies have demonstrated somewhat 
controversial roles of 5-HT in social hierarchies.  In human studies, the administration 
of SSRIs that increases 5-HT transmission has been found to facilitate social affiliation 
(Knutson et al., 1998).  In contrast, another study involving the oral administration of 
tryptophan, which increases central nervous system 5-HT synthesis and metabolism (De 
Simoni et al., 1987) and thereby may in turn increase 5-HT transmission, demonstrated 
increased social dominance (Moskowitz et al., 2001).  Thus, these two intuitively 
confronting traits were facilitated by increased 5-HT transmission.  In non-human 
primates living in social groups, higher CSF levels of the 5-HT metabolite 
5-hydroxyindoleacetic acid (5-HIAA) were found in subordinates than dominants 
(Riddick et al., 2009).  Studies have also demonstrated that with higher CSF 5-HIAA 
concentrations, rhesus macaques exhibit less aggressive behavior (Westergaard et al., 
2003), whereas vervet monkeys exhibit less impulsive behavior (Fairbanks et al., 2001), 
which predicts lower social class in these two species.  In contrast, another study found 
that the administration of drugs that increase and decrease 5-HT transmission to a pair 
of non-human primates results in a dominant status in the subject who receives the drug 
that increases 5-HT release and a subordinate status in the other subject who receives a 
drug that decreases 5-HT release, which suggests that higher 5-HT transmission is 
important for higher social class (Raleigh et al., 1991).  These controversial findings 
can be reconciled by considering the distinct roles of 5-HT transmission in social 
dominance between high and low social class subjects.  Larson and Summers reported 
that the administration of SSRIs to a dominant males Anolis carolinensis attenuated 
dominance over subordinates, whereas the same treatment applied to the subordinates 
attenuated submission toward dominants (Larson and Summers, 2001).  A similar 
finding has also been reported in a recent study with cynomolgus monkeys; the 
administration of SSRIs to the dominants and subordinates attenuated dominant and 
submissive behaviors, respectively (Shively et al., 2014).  Consistent with these studies, 
5-HT gene polymorphisms have also been associated with the rigidity of the social 
hierarchies of macaque species.  The prevalence of alleles that result in low 5-HT 
transmission is higher in macaque species that organize strict social hierarchies than in 
species with relaxed social hierarchies (Canli and Lesch, 2007).  These studies suggest 
that low 5-HT transmission is clearly disadvantageous in high social class subjects, 
whereas low 5-HT transmission yields beneficial effects in low social class subjects.  
Because low 5-HT transmission is associated with affective dysfunction and MDD, 
alleles that result in low 5-HT signaling and increased risks of MDD may have been 
maintained through balancing selection among low social class subjects living in the 




5. Maternal Care as an Evolutionary Origin of Psychotic and Mood 
Disorders  
Psychotic and mood disorders involve neurodevelopmental deficits (Ansorge et al., 
2007; Arnsten and Rubia, 2012; Lewis and Levitt, 2002; Mullin et al., 2013).  Here we 
discuss a potential mechanism by which the neuordevelopmental process could be an 
important determinant for the selection of alleles associated with psychotic and mood 
disorders.  Specifically, studies have demonstrated that maternal care deprivation and 
physical abuse in early development result in the selection of alleles associated with 
increased risks for psychotic and mood disorders (Belsky and Hartman, 2014; Belsky et 
al., 2009; Homberg and Lesch, 2011).   
 Monoamine oxidase A (MAOA) is an enzyme that is located on the membrane 
of the mitochondria in presynaptic terminals and is involved in the degradation of 5-HT, 
DA, and norepinephrine (Chajkowski-Scarry and Rimoldi, 2014).  The promoter 
region of the MAOA gene has a 30-bp untranslated or upstream VNTR (μVNTR) that 
varies between 3, 3.5, 4, and 5 repeats (Sabol et al., 1998).  MAOA activity is higher 
with the 3.5 and 4 repeats (h-allele) than the 3 and 5 repeats (l-allele) (Sabol et al., 
1998).  Meta-analyses have demonstrated associations of the l-allele with increased 
risks of mood disorders (Fan et al., 2010b), but not SCZ (Li and He, 2008).  In 
macaques, 5, 6, or 7 repeats of the 18-bp VNTR that is orthologous to that of humans in 
the promoter region of the MAOA gene have also been identified (Newman et al., 2005).  
Transcriptional activity is lower (thereby resulting in high DA and 5-HT transmission) 
with the 7-repeat allele (l-allele) compared with the 5- or 6-repeat allele (h-allele) 
(Newman et al., 2005).  A study by Newman and colleagues demonstrated that rhesus 
macaques with the l-allele are more aggressive and competitive for food access than 
those with the h-allele when they are reared with normal maternal care (Newman et al., 
2005).  However, when macaques are raised under conditions of maternal care 
deprivation, this relationship is reversed; thus, the monkeys with the l-allele exhibit 
more aggressive and competitive behaviors than those with the s-allele.  Similar 
alterations have also been reported in humans (Enoch et al., 2010; Hill et al., 2013; 
Huizinga et al., 2006; Kim-Cohen et al., 2006; Wakschlag et al., 2010).  Children with 
the l-allele exhibit more severe antisocial behaviors, emotional problems, attention 
deficits, and hyperactivity than h-allele carriers when these children are reared in a 
normal maternal care conditions, whereas these tendencies are reversed among children 
who have experienced opposite physical abuse; the h-allele carriers exhibit more 
problems than the l-allele carriers.   
 5HTTLPR s-allele carriers also exhibit greater aggression and a higher 
incidence of MDD than l-allele carriers when they grow in conditions of normal 
maternal care; however, l-allele carriers are more aggressive and susceptible to MDD 
than s-allele carriers when are reared by caregivers and receive less maternal care 
(Belsky et al., 2009; Cicchetti et al., 2007; Humphreys et al., 2015).  In macaques, 
similar interactions between early adverse rearing conditions and functional alterations 
of the 5HTTLPR homologous to that of humans in the stress response (Barr et al., 2004) 
and visual orientation (Champoux et al., 2002) have also been reported.   
 The DRD4 gene has a 48-bp VNTR in exon 3 that ranges from 2 to 11 repeats, 
and 4 and 7 repeats are the most common (Van Tol et al., 1992).  Since the initial 
finding by LaHoste and colleagues (LaHoste et al., 1996), the 7-repeat (or longer) allele 
has been associated with an increased risk of ADHD, although this association has often 
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been controversial in subsequent studies (Faraone et al., 2001; Gonon et al., 2012; Hawi 
et al., 2000; Sullivan et al., 1998).  Meta-analyses have reported an association 
between the DRD4 VNTR and an increased risk of mood disorders (Lopez Leon et al., 
2005) but not SCZ (Glatt et al., 2003b).  The DRD4 genotype has also been associated 
with high novelty seeking (Ebstein et al., 1996).  The prevalence of the 7-repeat allele 
and longer allele is significantly higher (~50-70%) among nomadic settlements that 
migrated from northern Asia to the Americas than sedentary settlements (~10-15%); 
thus, the 7-repeat allele has been suggested to contribute to cross-continental 
macro-migration in relation to its association with high novelty seeking (Chen et al., 
1999; Matthews and Butler, 2011).  The associations between the DRD4 allele and 
cognitive and affective function have been less explored and remain unclear.  
Nevertheless, children with fewer than seven repeats have been demonstrated to 
perform better in cognitive tests, such as the Stroop test and continuous performance 
test, and to exhibit less externalizing behavior and less aggressive and impulsive 
behavior than those with 7 repeats or more; however, these relationships are reversed in 
children who receive less maternal care than normal cases (Bakermans-Kranenburg and 
van Ijzendoorn, 2006; Berry et al., 2014). 
 DRD2 TaqIA polymorphism is also subjected to functional alterations in 
response to adverse rearing conditions during early development.  Thus, DRD2 A1 
allele-carriers who are reared with poor maternal care exhibit greater novelty seeking 
than A1 allele-carriers who are reread with normal maternal care; however, this effect is 
absent in non-A1 allele-carriers (Keltikangas-Jarvinen et al., 2009). 
 Catechol-o-methyltransferase (COMT) is a soluble (sCOMT) or 
membrane-bound (mbCOMT) enzyme that regulates DA release by catabolizing DA 
molecules (Elsworth et al., 1987; Karoum et al., 1994), and its roles has been 
specifically suggested in the mesocortical DA pathway innervating into the prefrontal 
cortex (PFC) (Gasparini et al., 1997; Liljequist et al., 1997).  The COMT gene has a 
functional SNP (rs4680) at codon 158 that results in the replacement of valine with 
methionine (Val158Met) in humans.  COMT with valine exhibits higher activity that 
consequently lowers the extracellular DA concentration compared with COMT with 
methionine (Dickinson and Elvevag, 2009; Malhotra et al., 2002; Meyer-Lindenberg et 
al., 2006).  Given the Yerkes-Dodson relationship of mesocortical DA function (i.e., 
both DA transmission too high and too low causes deficits) (Seamans and Yang, 2004), 
it is difficult to determine which allele works advantageously for PFC function.  
However, meta-analyses of the influence of the COMT Val158Met polymorphism on 
cognitive function have revealed that although the effects are very weak and marginal at 
best, Met allele carriers perform better on cognitive tasks, such as working memory 
tasks (Barnett et al., 2008) and Wisconsin card sorting test (Barnett et al., 2007) than 
Val-allele carriers.  Meta-analyses have not found a significant association between the 
COMT Val158Met polymorphism and an increased risk of SCZ (Munafo et al., 2005).  
In one meta-analysis, an association was still found when the analysis was conducted 
with a stratification of the studies according to the ethnicity of the patients (Glatt et al., 
2003a), whereas another meta-analysis did not find an association even with such 
ethnicity stratification (Fan et al., 2005).  The COMT Val158Met polymorphism has 
also been demonstrated to be influenced by maternal care in early development.  In 
one study, children with the Val allele were found to be more aggressive than those with 
the Met allele; however, this relationship was reversed in offspring born to mothers who 
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frequently smoked during pregnancy (Brennan et al., 2011).  An interaction between 
the Val and Met alleles and the quality of parental care on cognitive function has also 
been reported in infants.  Infants with the Met allele exhibit greater cognitive ability 
than those with the Val allele when they are reared with good parental care, and the 
opposite relationship is observed with poor paternal care (Voelker et al., 2009).  An 
interaction between the Val and Met alleles and early childhood adversity on anxiety has 
also been reported; Met-allele carriers who have experienced severe childhood adversity 
exhibit more anxiety than those without such experience; however, this effect is absent 
in Val-allele carriers (Baumann et al., 2013).  The effects of an interaction between 
early stress experiences and the Val and Met alleles on working memory have been 
reported, although this finding has been contradicted in other cases (Ursini et al., 2011).  
Thus, Val-allele carriers exhibit worse performances in the working memory tests than 
Met-allele carriers, and this effect is further worsened in Val-allele carriers with early 
stress experiences. 
 Collectively, the alleles in the DA and 5-HT genes that are associated with 
increased risks of psychotic and mood disorders could be favorably selected for when 
early developmental environmental conditions are adverse.  By this selection, the 
diversity of the genetic pools may be secured to prepare for future adverse environments 
that are anticipated in subsequent generations.  This process may involve epigenetic 
mechanisms as suggested by a study that reported that maternal care may alter 
glucocorticoid receptor expression in the hippocampus, which in turn reduces anxiety 
and stress responses through epigenetic mechanisms (Weaver et al., 2004).  Consistent 
with this finding, early stress experiences have been demonstrated to decrease DNA 
methylation on the SNP site of the COMT gene (Abdolmaleky et al., 2006; Ursini et al., 
2011).   
 
6. Other Potential Mechanisms 
Here, we discuss two additional mechanisms that still remains more speculative due to 
the limited evidence.  One of these mechanisms is the selection of alleles based on the 
construction of friendship networks in which subjects of the same genotypes tend to 
make friends.  The other mechanism is the selection of alleles based on symbiosis with 
parasitic protozoans and gut microbiota that produce neurotransmitters and thereby 
influence the neural activities of their hosts. 
 
6.1. Social Network Homophily as an Evolutionary Origin of Psychotic and Mood 
Disorders  
Accumulating evidence suggests that individuals with similar personalities and 
behavioral traits tend to coordinate friendships, which is known as homophily.  For 
example, higher incidences of obesity (Christakis and Fowler, 2007), drug abuse  
(Christakis and Fowler, 2008; Rosenquist et al., 2010; Shakya et al., 2012), and 
emotional states, such as happiness (Fowler and Christakis, 2008) and depression 
(Rosenquist et al., 2011), are observed between friends than between strangers.  The 
genetic backgrounds of subjects have been demonstrated to play important roles in such 
friendship network homophily.  Thus, subjects with the same (homophilous) or 
opposite (heterophilous) genotypes tend to create friendships (Christakis and Fowler, 
2014).  One such genotype that is involved in social network homophily in human 
subjects is that of DRD2 (Fowler et al., 2011).  In non-human primates, friendship 
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network homophily as determined by affiliative contact, such as grooming between 
subjects, has been associated with 5HTTLPR and TPH2 alleles (Brent et al., 2013). 
 Upon consideration of these studies, it is plausible that alleles associated with 
increased risks of psychotic and mood disorders may be maintained in social networks 
that are organized by people who have the same alleles.  This notion is consistent with 
an argument that we recently proposed; i.e., psychiatric disorders may not necessarily 
work disadvantageously among afflicted individuals in a social network conditions that 
consist only of afflicted individuals (Lee and Goto, 2013).  It is also important to note 
that friendship and mate choice are functionally different, and mate choice but not 
friendship is crucial for the functioning of selection.  Nonetheless, because no gender 
specificity has been observed in the organization of friendships among individuals with 
the the same genotypes, assortative mate choice may indeed occur through the extension 
of male-female friendships.  This notion is supported by a recent study that concluded 
that nonrandom mating is evident in psychiatric populations both within specific 
disorders and across the spectrum of psychiatric condition, such that in regard to 
choosing a partner, people actually tend to pair up with those similar to them; i.e., 
partners tend to be more alike in their psychiatric statuses. (Nordsletten et al., 2016). 
 
6.2. Symbiosis as an Evolutionary Origin of Psychotic and Mood Disorders 
DA function follows the Yerkes-Dodson law; i.e., both DA concentrations that are too 
low or too high cause dysfunction (Seamans and Yang, 2004).  Thus, environmental 
conditions that increase DA release may favorably work for carriers of a genetic variant 
that leads to low basal DA concentrations (e.g. the COMT Val allele), whereas the same 
environmental conditions would produce detrimental effects for subjects with genetic 
variants that cause high basal DA levels (e.g. the COMT Met allele).  One such 
environmental factor may be Toxoplasma Gondii (T. Gondii).  T. Gondii is a parasitic 
protozoan that penetrates the blood-brain barrier and forms cysts in the central nervous 
system (Montoya and Liesenfeld, 2004).  Offspring born to mothers infected with T. 
Gondii have been demonstrated to be at an increased risk of SCZ (Brown et al., 2005).  
Rodents infected with T. Gondii have been found to exhibit increased DA 
concentrations in brain regions such as the limbic structures (Stibbs, 1985).  These 
increases appear to be associated with a mechanism involving the fact that T. Gondii has 
its own rate-limiting enzyme for catecholamine synthesis, i.e., tyrosine hydroxylase 
(Gaskell et al., 2009).  Thus, the DA synthesized in the T. Gondii cysts may be released 
into infected regions. 
 Accumulating evidence suggests that neural activity is also subject to a 
significant influence of the gut microbiota (Mayer et al., 2014).  In rodents, infection 
with a sub-clinical dose of campylobacter jejuni has been demonstrated to heighten 
anxiety (Goehler et al., 2008; Lyte et al., 1998), whereas probiotics, such as lactobacillis 
(Bravo et al., 2011) and bifidobacterium (Bercik et al., 2011), attenuate anxiety.  
Infection with the parasitic nematode Trichuris muris decreases brain-derived 
neurotrophic factor (BDNF) expression in the hippocampus, which is reversed by the 
promotion of gut bifidobacterium (Bercik et al., 2010).  In human subjects, the 
consumption of fermented milk foods for 4 weeks has been demonstrated to attenuate 
emotional responses and anxiety in addition to altering cortical neuronal network 
activity in response to negative stimuli (Messaoudi et al., 2011; Tillisch et al., 2013).  
Lyte proposed that the neurotransmitter molecules synthesized by microbiota, including 
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DA (by bacillus and serratia) and 5-HT (by candida, streptococcus, escherichia, and 
enterococcus), may be transported into the central nervous system and affect neuronal 
activity (Lyte et al., 2011).  Studies have also revealed that the composition of the gut 
microbiota significantly depends on the genotype (Khachatryan et al., 2008) and ethnic 
group (De Filippo et al., 2010) of the host. 
 Collectively, symbiosis with these parasitic protozoans and gut microbiota may 
also affect the selection of alleles associated with psychotic and mood disorders. 
 
7. Conclusions 
We have presented the following biological mechanisms that may explain the selection 
of DA and 5-HT alleles that are associated with increased risks of psychotic and mood 
disorders: (1) social competitiveness/hierarchy, (2) maternal care, (3) social network 
homophily, and (4) symbiosis.  Presently, various psychotic and mood disorder 
candidate genes have already been identified.  The specific genetic variants of DA and 
5-HT genes associated with increased risks of psychotic and mood disorders mentioned 
in this article are summarized in Table 1.  Although they cause disadvantageous 
phenotypes, these alleles have not been extinguished from the population.  Although 
psychotic and mood disorders may be byproducts of the evolution of brain function on 
the one hand, these disorders can also be understood as evolutionary adaptations that 
have been maintained under specific environmental conditions on the other hand.  
Consequently, the presence of psychotic and mood disorders could retain population 
diversity that enables preparation for adverse environmental conditions that are 
anticipated in future generations.  Investigations of the biological mechanisms of 
psychotic and mood disorders from the evolutionary perspective are a promising new 
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Table 1. The list of genetic variants in the DA and 5-HT genes for which meta-analyses 
and large scale GWAS have shown associations with psychotic and mood disorders. 
 
Genes Variants Disorders References 
DRD2 rs2514218 Schizophrenia (Schizophrenia Working Group of the 
Psychiatric Genomics, 2014) 
 rs1801028 (Ser311Cys) Schizophrenia (Yao et al., 2015) 
(Liu et al., 2012) 
(Glatt and Jonsson, 2006) 
 rs6277 (C957T) Schizophrenia (Liu et al., 2014) 
(Betcheva et al., 2009) 
(Fan et al., 2010a) 
(Monakhov et al., 2008) 
 rs1799732 (-141 Ins/Del) Schizophrenia (Cordeiro et al., 2009) 
 rs1800497 (TaqIA) Mood disorder (Zou et al., 2012)
  
DRD1 rs5326 (G-94A) Schizophrenia (Pan et al., 2014) 
(but no association in (Allen et al., 
2008))
  
TPH1 rs1800532 Mood disorder (Gizatullin et al., 2006) 
(Gatt et al., 2015)
  
TPH2 rs4570625 Mood disorder (Gao et al., 2012)
  
5HTT 5HTTLPR Mood disorder (Lotrich and Pollock, 2004) 
(Lasky-Su et al., 2005) 
(Clarke et al., 2010) 
  
MAOA μVNTR Mood disorder (Fan et al., 2010b) 
  
DRD4 48bp VNTR Mood disorder (Lopez Leon et al., 2005) 
  
COMT rs4860 (Val158Met) Schizophrenia 
(in specific ethnicity) 
(Glatt et al., 2003a) 
(but no association in (Fan et al., 2005) 
and (Munafo et al., 2005)) 
 
 
